Cite
HARVARD Citation
Balabanski, L. et al. (2021). Rare genetic variants prioritize molecular pathways for semaphorin interactions in Alzheimer's disease patients. Biotechnology, biotechnological equipment. 35 (1), pp. 1256-1262. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Balabanski, L. et al. (2021). Rare genetic variants prioritize molecular pathways for semaphorin interactions in Alzheimer's disease patients. Biotechnology, biotechnological equipment. 35 (1), pp. 1256-1262. [Online].